These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31155282)

  • 21. Channelopathy-causing mutations in the S
    Orfali R; Nam YW; Nguyen HM; Rahman MA; Yang G; Cui M; Wulff H; Zhang M
    Cell Calcium; 2022 Mar; 102():102538. PubMed ID: 35030515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of KCNN3/SK3/K(Ca)2.3 channels attenuates enhanced calcium influx and inflammatory cytokine production in activated microglia.
    Dolga AM; Letsche T; Gold M; Doti N; Bacher M; Chiamvimonvat N; Dodel R; Culmsee C
    Glia; 2012 Dec; 60(12):2050-64. PubMed ID: 23002008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension.
    Koot BG; Alders M; Verheij J; Beuers U; Cobben JM
    J Hepatol; 2016 Apr; 64(4):974-7. PubMed ID: 26658685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinically Relevant
    Bauer CK; Holling T; Horn D; Laço MN; Abdalla E; Omar OM; Alawi M; Kutsche K
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia.
    Grube S; Gerchen MF; Adamcio B; Pardo LA; Martin S; Malzahn D; Papiol S; Begemann M; Ribbe K; Friedrichs H; Radyushkin KA; Müller M; Benseler F; Riggert J; Falkai P; Bickeböller H; Nave KA; Brose N; Stühmer W; Ehrenreich H
    EMBO Mol Med; 2011 Jun; 3(6):309-19. PubMed ID: 21433290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An amino acid outside the pore region influences apamin sensitivity in small conductance Ca2+-activated K+ channels.
    Nolting A; Ferraro T; D'hoedt D; Stocker M
    J Biol Chem; 2007 Feb; 282(6):3478-86. PubMed ID: 17142458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic coupling between TRPV4 and Ca
    Li Y; Hu H; Tian JB; Zhu MX; O'Neil RG
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1081-F1089. PubMed ID: 28274924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital marked hypertrichosis and Laband syndrome in a child: overlap between the gingival fibromatosis-hypertrichosis and Laband syndromes.
    Lacombe D; Bioulac-Sage P; Sibout M; Daussac E; Lesure F; Manchart JP; Battin J
    Genet Couns; 1994; 5(3):251-6. PubMed ID: 7811425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein kinase CK2 is coassembled with small conductance Ca(2+)-activated K+ channels and regulates channel gating.
    Bildl W; Strassmaier T; Thurm H; Andersen J; Eble S; Oliver D; Knipper M; Mann M; Schulte U; Adelman JP; Fakler B
    Neuron; 2004 Sep; 43(6):847-58. PubMed ID: 15363395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potassium Channel KCNH1 Activating Variants Cause Altered Functional and Morphological Ciliogenesis.
    Napoli G; Panzironi N; Traversa A; Catalanotto C; Pace V; Petrizzelli F; Giovannetti A; Lazzari S; Cogoni C; Tartaglia M; Carella M; Mazza T; Pizzuti A; Parisi C; Caputo V
    Mol Neurobiol; 2022 Aug; 59(8):4825-4838. PubMed ID: 35639255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zimmermann-Laband syndrome: a case report.
    Sawaki K; Mishima K; Sato A; Goda Y; Osugi A; Nakano M
    J Clin Pediatr Dent; 2012; 36(3):297-300. PubMed ID: 22838235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Domains responsible for constitutive and Ca(2+)-dependent interactions between calmodulin and small conductance Ca(2+)-activated potassium channels.
    Keen JE; Khawaled R; Farrens DL; Neelands T; Rivard A; Bond CT; Janowsky A; Fakler B; Adelman JP; Maylie J
    J Neurosci; 1999 Oct; 19(20):8830-8. PubMed ID: 10516302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity.
    Anon B; Largeau B; Girault A; Chantome A; Caulet M; Perray C; Moussata D; Vandier C; Barin-Le Guellec C; Lecomte T
    Cancer Chemother Pharmacol; 2018 Jul; 82(1):149-157. PubMed ID: 29774408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons.
    Wolfart J; Neuhoff H; Franz O; Roeper J
    J Neurosci; 2001 May; 21(10):3443-56. PubMed ID: 11331374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDAC2-dependent remodeling of K
    Rahm AK; Wieder T; Gramlich D; Müller ME; Wunsch MN; El Tahry FA; Heimberger T; Weis T; Most P; Katus HA; Thomas D; Lugenbiel P
    Life Sci; 2021 Feb; 266():118892. PubMed ID: 33310041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction.
    Padula AE; Griffin WC; Lopez MF; Nimitvilai S; Cannady R; McGuier NS; Chesler EJ; Miles MF; Williams RW; Randall PK; Woodward JJ; Becker HC; Mulholland PJ
    Neuropsychopharmacology; 2015 Jul; 40(8):1928-39. PubMed ID: 25662840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unstructured to structured transition of an intrinsically disordered protein peptide in coupling Ca²⁺-sensing and SK channel activation.
    Zhang M; Pascal JM; Zhang JF
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4828-33. PubMed ID: 23487779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EF hands at the N-lobe of calmodulin are required for both SK channel gating and stable SK-calmodulin interaction.
    Li W; Halling DB; Hall AW; Aldrich RW
    J Gen Physiol; 2009 Oct; 134(4):281-93. PubMed ID: 19752189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CACNA1I gain-of-function mutations differentially affect channel gating and cause neurodevelopmental disorders.
    El Ghaleb Y; Schneeberger PE; Fernández-Quintero ML; Geisler SM; Pelizzari S; Polstra AM; van Hagen JM; Denecke J; Campiglio M; Liedl KR; Stevens CA; Person RE; Rentas S; Marsh ED; Conlin LK; Tuluc P; Kutsche K; Flucher BE
    Brain; 2021 Aug; 144(7):2092-2106. PubMed ID: 33704440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extensive molecular genetic analysis of the 3p14.3 region in patients with Zimmermann-Laband syndrome.
    Abo-Dalo B; Kim HG; Roes M; Stefanova M; Higgins A; Shen Y; Mundlos S; Quade BJ; Gusella JF; Kutsche K
    Am J Med Genet A; 2007 Nov; 143A(22):2668-74. PubMed ID: 17937436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.